Ocular Therapeutix: Q3 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Tuesday reported a loss of $516,000 in its third quarter.

The Bedford, Massachusetts-based company said it had a loss of 25 cents per share. Losses, adjusted to extinguish debt and for non-recurring gains, came to 51 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

The biotechnology company posted revenue of $15.1 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $15.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL

Advertisement

Recommended Stories